Investors evaluating construction-materials equities often weigh exposure to different housing, infrastructure, and commercial-building cycles. This stock comparison examines AMRZ (Amrize Ltd) and CX (CEMEX, S.A.B. de C.V.), two companies operating at different stages of their corporate lifecycles and in different regional markets. Amrize is a recently spun-off, North America-focused building-solutions provider, while CEMEX is a long-established global cement and ready-mix concrete producer headquartered in Mexico. Traders tracking relative performance and market positioning in the materials sector, as well as longer-term investors comparing growth drivers and balance-sheet dynamics, may find this comparison relevant.
AMRZ (Amrize Ltd) is a North American building-solutions company offering cement, aggregates, ready-mix concrete, asphalt, roofing systems, and wall systems across its Building Materials and Building Envelope segments. Formerly known as Holcim North America, the company became an independent, publicly traded entity in mid-2025 and is listed on both the New York Stock Exchange and the SIX Swiss Exchange. Amrize reported approximately $11.8 billion in revenue for 2025.
In recent months, the company has emphasized capital returns, announcing a $1 billion share buyback program that commenced in May 2026. Management commentary around recent quarterly results pointed to resilient demand in select building-envelope categories, with one segment reporting revenue growth of roughly 9% on a year-over-year basis. Investor sentiment has been shaped by the company's post-spinoff execution, its exposure to North American construction activity, and its focus on returning value to shareholders.
CX (CEMEX, S.A.B. de C.V.) is a Mexico-based global construction-materials company producing and distributing cement, ready-mix concrete, aggregates, and related products across more than 50 countries. Its largest market is Mexico, with additional operations in the United States, Europe, and other regions. CEMEX has been executing a transformation strategy centered on cost efficiency and the divestiture of non-core assets.
Recent results reflected that strategy. In its latest quarter, CEMEX reported operating EBITDA of roughly $990 million, an increase of about 12% year over year, while net sales rose approximately 8%, supported by higher gray-cement volumes and a 16% gain in Mexican revenue. The company has also continued asset sales and cost-reduction efforts under its "Project Cutting Edge" initiative. Despite constructive fundamentals, the stock has faced pressure tied to higher U.S. interest rates, and several analysts have recently reaffirmed or raised their ratings while citing an improving Mexican property outlook.
Tickeron's Trending AI Robots page highlights a curated selection of automated trading systems drawn from a much larger universe of hundreds of AI trading bots that collectively trade thousands of different tickers. Only the bots considered most suitable for current market conditions earn a place in this featured section. These systems vary widely in trading style, strategy, timeframe, performance statistics, and the specific tickers they follow, allowing traders to compare approaches rather than relying on a single model. The page is designed to help users identify automated strategies aligned with their own market outlook. To explore the latest top-performing systems, visit Trending AI Robots.
The clearest contrast between AMRZ and CX lies in geography and corporate maturity. Amrize is a concentrated North American platform still establishing itself as an independent company, which gives it a simpler, more predictable operating footprint but ties its results closely to U.S. and Canadian construction demand. CEMEX offers broader diversification across emerging and developed markets, but its profile carries greater currency and country-specific risk.
Growth drivers also differ. Amrize's story centers on post-spinoff execution, building-envelope demand, and shareholder returns through buybacks. CEMEX's momentum is driven by cost discipline, divestitures, and a recovering Mexican housing market. On risk, CEMEX remains more sensitive to interest-rate movements and macroeconomic volatility, while Amrize faces the execution and integration risks common to newly independent companies. In terms of market sentiment, analyst coverage of CX is currently constructive, whereas Amrize's younger public history means investors are still forming a longer-term view of its standalone value.
Based on observable factors such as trend consistency, catalyst visibility, and relative positioning, Tickeron's AI framework would likely lean toward CX in the current environment. CEMEX combines improving operating momentum, a clear cost-reduction catalyst, and a more established analyst consensus, which tend to support steadier signal quality in automated trend and momentum models. AMRZ, by contrast, offers a compelling capital-return narrative but presents a shorter public track record and less settled market positioning. These are probabilistic assessments of relative strength rather than definitive conclusions, and outcomes will depend on how each company's catalysts and risk factors evolve.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for AMRZ crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on AMRZ as a result. In 12 of 23 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 52%.
AMRZ moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMRZ advanced for three days, in 44 of 68 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 26 of 51 cases where AMRZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 51%.
The 10-day RSI Indicator for AMRZ moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 8 similar instances where the indicator moved out of overbought territory. In 6 of the 8 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMRZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
AMRZ broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. AMRZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 71 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.780) is normal, around the industry mean (2.594). P/E Ratio (18.776) is within average values for comparable stocks, (21.516). Projected Growth (PEG Ratio) (1.040) is also within normal values, averaging (0.876). Dividend Yield (0.011) settles around the average of (0.048) among similar stocks. P/S Ratio (1.746) is also within normal values, averaging (2.242).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMRZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock worse than average.
CX moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend. In 28 of 33 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 85%.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on CX as a result. In 64 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for CX just turned positive on October 06, 2026. Looking at past instances where CX's MACD turned positive, the stock continued to rise in 32 of 42 cases over the following month. The odds of a continued upward trend are 76%.
The 10-day moving average for CX crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +2.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where CX advanced for three days, in 220 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 198 of 278 cases where CX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The 10-day RSI Indicator for CX moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 49 similar instances where the indicator moved out of overbought territory. In 27 of the 49 cases, the stock moved lower in the following days. This puts the odds of a move lower at 55%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 57 cases where CX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
CX broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 41 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. CX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CX's P/B Ratio (1.235) is slightly lower than the industry average of (2.594). P/E Ratio (31.905) is within average values for comparable stocks, (21.516). CX's Projected Growth (PEG Ratio) (1.940) is slightly higher than the industry average of (0.876). Dividend Yield (0.012) settles around the average of (0.048) among similar stocks. P/S Ratio (0.860) is also within normal values, averaging (2.242).
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 41 | |
SMR RATING 1..100 | 86 | |
PRICE GROWTH RATING 1..100 | 55 | |
P/E GROWTH RATING 1..100 | 3 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| AMRZ | CX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 55% |
| Stochastic ODDS (%) | 1 day ago 67% | 1 day ago 61% |
| Momentum ODDS (%) | 1 day ago 52% | 1 day ago 79% |
| MACD ODDS (%) | N/A | 3 days ago 76% |
| TrendWeek ODDS (%) | 1 day ago 66% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 57% | 1 day ago 73% |
| Advances ODDS (%) | 19 days ago 65% | 20 days ago 73% |
| Declines ODDS (%) | 1 day ago 70% | about 1 month ago 70% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 53% |
| Aroon ODDS (%) | 1 day ago 51% | 1 day ago 71% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMRZ’s FA Score shows that 0 FA rating(s) are green while CX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMRZ’s TA Score shows that 5 TA indicator(s) are bullish while CX’s TA Score has 6 bullish TA indicator(s).
AMRZ (@Construction Materials) experienced а +1.18% price change this week, while CX (@Construction Materials) price change was +0.19% for the same time period.
The average weekly price growth across all stocks in the @Construction Materials industry was -1.72%. For the same industry, the average monthly price growth was -1.30%, and the average quarterly price growth was -20.62%.
AMRZ is expected to report earnings on Feb 23, 2027.
CX is expected to report earnings on Feb 18, 2027.
Many naturally occurring substances, such as clay, rocks, sand, and wood, even twigs and leaves have been used in construction material. Many man-made products are also in use. Vulcan Materials Co., Martin Marietta Materials, Inc. and Owens Corning Inc. are examples of construction material companies in the U.S. Performance of companies that extract or produce construction materials could at times depend on demand for residential and commercial buildings/real estate, and therefore in some cases could feel impacted by economic cycles.
A.I.dvisor indicates that over the last year, AMRZ has been loosely correlated with MLM. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRZ jumps, then MLM could also see price increases.
| Ticker / NAME | Correlation To AMRZ | 1D Price Change % | ||
|---|---|---|---|---|
| AMRZ | 100% | -1.83% | ||
| MLM - AMRZ | 64% Loosely correlated | -1.83% | ||
| EXP - AMRZ | 64% Loosely correlated | -1.69% | ||
| CRH - AMRZ | 63% Loosely correlated | -0.67% | ||
| VMC - AMRZ | 62% Loosely correlated | -0.98% | ||
| TTAM - AMRZ | 59% Loosely correlated | -3.60% | ||
More | ||||
A.I.dvisor indicates that over the last year, CX has been loosely correlated with AMRZ. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CX jumps, then AMRZ could also see price increases.